McKesson Corporation (MCK) SEC Filings & Earnings Calls

Regulatory approval risk; transaction expected to close in H1 2027 subject to stockholder and regulatory approvals.

“Transaction subject to customary closing conditions, including approval by Option Care Health’s stockholders and receipt of required regulatory approvals.”

Option Care Health withdraws 2026 guidance; uncertainty about near-term financial performance.

“Option Care Health is withdrawing its previously disclosed financial guidance.”

Cybersecurity incident; potential material impact on financial condition or operations not yet determined.

“cybersecurity incident affecting its information systems” · word for word

Opioid litigation liability

“total estimated litigation liability of $5.7 billion as of June 30, 2026 payable under the terms of various settlement agreements for opioid-related claims” · word for word

Restructuring execution risk

“We recorded restructuring, impairment, and related charges of $136 million and $47 million for the three months ended June 30, 2026 and 2025, respectively.” · word for word

Customer concentration / Rite Aid bankruptcy impact

“related to the bankruptcy of our customer Rite Aid, we recorded a provision for bad debts of $189 million during the three months ended June 30, 2025” · word for word

Regulatory uncertainty

“our industry is highly regulated and is subject to risks and uncertainty caused by the volume and speed of changes to regulatory policies.” · word for word

Planned separation of Medical-Surgical Solutions segment may not be completed on expected terms or timeline.

“Our planned separation of Medical-Surgical Solutions is contingent upon the satisfaction of certain conditions, may not be completed on the currently contemplated terms or timeline, or at all, and, if completed, may not achieve the intended financial and strategic benefits.” · word for word

Ongoing legal disputes and settlements related to opioid distribution.

“We experience costly and disruptive legal disputes and settlements, including regarding our role in distributing controlled substances such as opioids.” · word for word

Cybersecurity incidents could compromise technology systems or result in data breaches.

“We experience cybersecurity incidents that might significantly compromise our technology systems or might result in material data breaches.” · word for word

Loss of key strategy executive may affect long-term strategic initiatives.

“Departure of EVP, Chief Strategy and Business Development Officer.”

Increased leverage from new term loan facility.

“Creation of a direct financial obligation under Item 2.03.”

Customer concentration risk

“Sales to our ten largest customers, including group purchasing organizations (GPOs), accounted for approximately 73% of total consolidated revenues in fiscal 2026 and comprised approximately 43% of total trade accounts receivable at March 31, 2026. Sales to our largest customer, CVS Health Corporation (CVS), accounted for approximately 24% of our total conso” · word for word

Opioid litigation liability

“At March 31, 2026, our estimated accrued liability for opioid-related claims was $5.7 billion. We are not able to reasonably estimate the upper or lower ends of the range of ultimate possible losses for all opioid-related litigation matters.” · word for word

Portfolio transformation (Europe divestiture, Medical-Surgical separation) creates execution risk.

“Continuing to optimize our portfolio through the divestiture of Europe and the planned separation of our Medical-Surgical business.” · word for word

Dependence on branded pharmaceutical pricing and volume trends.

“Growth in North American Pharmaceutical segment due to increased prescription volumes, partially offset by lower contributions from branded pharmaceuticals.”

Termination of existing credit facilities; new facility may have different terms.

“Termination of Existing Credit Facilities effective upon entry into New Revolving Credit Facility.”

Increased leverage from new credit facility

“New credit agreement may increase debt obligations; no specific amounts disclosed in excerpt.”

CFO departure may signal leadership transition risk.

“CFO Britt Vitalone transitions to advisor role.”

Medical-Surgical Solutions segment profit down 10% due to lower volumes in physician office settings and lower illness incidence.

“Medical-Surgical Solutions Segment Operating Profit was $265 million, a decrease of 10%, driven by lower volumes across physician office settings and lower incidence of illness for the season.”

Opioid litigation liability

“total estimated litigation liability of $5.7 billion as of December 31, 2025 payable under the terms of various settlement agreements for opioid-related claims” · word for word

Regulatory uncertainty

“our industry is highly regulated and is subject to risks and uncertainty caused by the volume and speed of changes to regulatory policies.” · word for word

Restructuring execution risk

“We anticipate total charges related to these initiatives of $650 million to $700 million, consisting primarily of employee severance and other employee-related costs as well as facility, exit, and other related costs, including long-lived asset impairments.” · word for word

Opioid litigation liability

“Funds necessary for future debt maturities and our other cash requirements, including any future payments that may be made related to our total estimated litigation liability of $5.7 billion as of September 30, 2025 payable under the terms of various settlement agreements for opioid-related claims.” · word for word

Regulatory uncertainty

“Changes in U.S. federal regulatory posture and law may result in significant changes in healthcare policy, government funding of healthcare costs, and other laws affecting our operations, but the ultimate outcomes are difficult to predict.” · word for word